223 related articles for article (PubMed ID: 23332394)
1. Bath-PUVA therapy decreases infiltrating CCR4-expressing tumor cells and regulatory T cells in patients with mycosis Fungoides.
Kato H; Saito C; Ito E; Furuhashi T; Nishida E; Ishida T; Ueda R; Inagaki H; Morita A
Clin Lymphoma Myeloma Leuk; 2013 Jun; 13(3):273-80. PubMed ID: 23332394
[TBL] [Abstract][Full Text] [Related]
2. Role of bath psoralen plus ultraviolet A in early-stage mycosis fungoides.
Pavlotsky F; Hodak E; Ben Amitay D; Barzilai A
J Am Acad Dermatol; 2014 Sep; 71(3):536-41. PubMed ID: 24836546
[TBL] [Abstract][Full Text] [Related]
3. Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides.
Kakinuma T; Sugaya M; Nakamura K; Kaneko F; Wakugawa M; Matsushima K; Tamaki K
J Am Acad Dermatol; 2003 Jan; 48(1):23-30. PubMed ID: 12522366
[TBL] [Abstract][Full Text] [Related]
4. Bath-PUVA therapy improves impaired resting regulatory T cells and increases activated regulatory T cells in psoriasis.
Kubo R; Muramatsu S; Sagawa Y; Saito C; Kasuya S; Nishioka A; Nishida E; Yamazaki S; Morita A
J Dermatol Sci; 2017 Apr; 86(1):46-53. PubMed ID: 28139335
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides.
Wackernagel A; Hofer A; Legat F; Kerl H; Wolf P
Br J Dermatol; 2006 Mar; 154(3):519-23. PubMed ID: 16445785
[TBL] [Abstract][Full Text] [Related]
6. Reduction of regulatory T cells by Mogamulizumab, a defucosylated anti-CC chemokine receptor 4 antibody, in patients with aggressive/refractory mycosis fungoides and Sézary syndrome.
Ni X; Jorgensen JL; Goswami M; Challagundla P; Decker WK; Kim YH; Duvic MA
Clin Cancer Res; 2015 Jan; 21(2):274-85. PubMed ID: 25376389
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056).
Whittaker S; Ortiz P; Dummer R; Ranki A; Hasan B; Meulemans B; Gellrich S; Knobler R; Stadler R; Karrasch M
Br J Dermatol; 2012 Sep; 167(3):678-87. PubMed ID: 22924950
[TBL] [Abstract][Full Text] [Related]
8. Bath-water PUVA therapy with 8-methoxypsoralen in mycosis fungoides.
Weber F; Schmuth M; Sepp N; Fritsch P
Acta Derm Venereol; 2005; 85(4):329-32. PubMed ID: 16191854
[TBL] [Abstract][Full Text] [Related]
9. Bath Psoralen-ultraviolet A and Narrowband Ultraviolet B Phototherapy as Initial Therapy for Early-stage Mycosis Fungoides: A Retrospective Cohort of 267 Cases at the University of Toronto.
Almohideb M; Walsh S; Walsh S; Shear N; Alhusayen R
Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):604-612. PubMed ID: 28711574
[TBL] [Abstract][Full Text] [Related]
10. Bath-PUVA therapy induces circulating regulatory T cells in patients with psoriasis.
Saito C; Maeda A; Morita A
J Dermatol Sci; 2009 Mar; 53(3):231-3. PubMed ID: 19070466
[No Abstract] [Full Text] [Related]
11. CD30+ large cell transformation of mycosis fungoides after psoralen plus ultraviolet A photochemotherapy.
Ogino J; Saga K; Kagaya M; Kamada A; Hirosaki K; Kaneko R; Jimbow K
Br J Dermatol; 2007 Jan; 156(1):148-51. PubMed ID: 17199582
[TBL] [Abstract][Full Text] [Related]
12. Narrow band UVB (311 nm), psoralen UVB (311 nm) and PUVA therapy in the treatment of early-stage mycosis fungoides: a right-left comparative study.
El-Mofty M; El-Darouty M; Salonas M; Bosseila M; Sobeih S; Leheta T; Nada H; Tawdy A; Amin I; El-Enany G
Photodermatol Photoimmunol Photomed; 2005 Dec; 21(6):281-6. PubMed ID: 16313238
[TBL] [Abstract][Full Text] [Related]
13. A chart review of patients with early stage mycosis fungoides treated with psoralen plus UVA (PUVA).
Soung J; Muigai W; Amin N; Stern DK; Lebwohl MG
J Drugs Dermatol; 2005; 4(3):290-4. PubMed ID: 15898283
[TBL] [Abstract][Full Text] [Related]
14. Production of thymus and activation-regulated chemokine and macrophage-derived chemokine by CCR4+ adult T-cell leukemia cells.
Shimauchi T; Imai S; Hino R; Tokura Y
Clin Cancer Res; 2005 Mar; 11(6):2427-35. PubMed ID: 15788694
[TBL] [Abstract][Full Text] [Related]
15. Interferon-alpha is effective for CD4(+), CCR4(-) mycosis fungoides.
Fujimura T; Okuyama R; Watabe A; Hashimoto A; Tagami H; Aiba S
Int J Dermatol; 2007 Apr; 46(4):435-8. PubMed ID: 17442093
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of narrowband UVB vs. PUVA in patients with early-stage mycosis fungoides.
Ponte P; Serrão V; Apetato M
J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):716-21. PubMed ID: 19929938
[TBL] [Abstract][Full Text] [Related]
17. Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma.
Watanabe Y; Katou F; Ohtani H; Nakayama T; Yoshie O; Hashimoto K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):744-52. PubMed ID: 20303300
[TBL] [Abstract][Full Text] [Related]
18. Broad band UVA: a possible reliable alternative to PUVA in the treatment of early-stage mycosis fungoides.
El Mofty M; Ramadan S; Fawzy MM; Hegazy RA; Sayed S
Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):274-7. PubMed ID: 22971197
[TBL] [Abstract][Full Text] [Related]
19. Psoralen plus ultraviolet A +/- interferon-alpha treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-kappaB and T-cell receptor pathways.
Wozniak MB; Tracey L; Ortiz-Romero PL; Montes S; Alvarez M; Fraga J; Fernández Herrera J; Vidal S; Rodriguez-Peralto JL; Piris MA; Villuendas Deceased R
Br J Dermatol; 2009 Jan; 160(1):92-102. PubMed ID: 18945306
[TBL] [Abstract][Full Text] [Related]
20. CCR4 is expressed on infiltrating cells in lesional skin of early mycosis fungoides and atopic dermatitis.
Sugaya M; Morimura S; Suga H; Kawaguchi M; Miyagaki T; Ohmatsu H; Fujita H; Sato S
J Dermatol; 2015 Jun; 42(6):613-5. PubMed ID: 25809616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]